Kura Oncology (KURA) Reports In-Line Q3 EPS

Kura Oncology (NASDAQ: KURA) reported Q3 EPS of ($0.63), in-line with the analyst estimate of ($0.63).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Clariant AG (CLN:SW) (CLZNY) PT Raised to CHF13 at JPMorgan
• Diginex reports 77% revenue rise but $31M net loss in FY2026